Dr. Andrew Pekosz and Dr. Jaiprasath Sachithanandham were part of a group of Johns Hopkins researchers who received a letter this week from the director of the National Institute of Allergies and Infectious Diseases, Dr. Anthony Fauci. Dr. Fauci recognized their work in sequencing and isolating emerging SARS-CoV-2 variants alongside collaborators from the School ofContinue reading “Members of Pekosz Lab Acknowledged by Dr. Anthony Fauci for their role in the COVID-19 pandemic response”
Position description below. [IMAGE TEXT: Postdoctoral Associate Position to Study Respiratory Virus-Epithelial Cell Interactions. A position is available to study SARS-CoV-2 infection of primary differentiated human nasal epithelial cell (hNEC) cultures. SARS-CoV-2 infects the upper and lower respiratory tract and replication can be influenced by physiological ranges in temperature (33C to 37C). This project willContinue reading “The Pekosz Lab is looking for a postdoc!”
Several members of the Pekosz lab were authors on a paper published in the Journal of Clinical Investigation last month “Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection.” This paper characterized immune responses to infection by the Alpha variant of SARS-CoV-2.
Dr. Pekosz’s guest essay was recently featured in the New York Times, discussing the present and future of disease severity caused by SARS-CoV-19 variants. Covid-19 becoming a milder disease is not a decision the virus will make, it’s a decision that all of us can make if we take advantage of the vaccines that canContinue reading “NYT Opinion Guest Essay: Will the Coronavirus Evolve to Be Milder?”